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1. Introduction 
Since the original purification of ferritin by 
Laufberger [l] using cadmium salt precipitation a 
number of purification techniques have been described 
using various combinations of heat denaturation and 
differential precipitation with ammonium sulphate 
together with ultra-centrifugation and various forms 
of column chromatography [23] . The disadvantages 
of these methods are two-fold. Firstly, they usually 
involve several stages during which protein denatura- 
tion may occur and secondly, the yield is often very 
low, the latter being a major problem when working 
with a source of ferritin of low concentration, e.g., 
normal serum. Furthermore, ultra-centrifugation tends 
to select only those ferritin molecules with a relatively 
high iron content. 
This paper describes a method of ferritin purifica- 
tion which can be applied to both tissue and serum 
ferritin and combines the advantages of a one-step 
purification with high yield of recovered ferritin. The 
method involves an adsorption phase using a specific 
immuno-adsorbent combined with a previously 
described preparative application of electrophoretic 
desorption [4]. This desorption method was compared 
with more conventional methods. 
2. Methods and materials 
Anti-human ferritin antibodies were raised in 
New Zealand white rabbits against human spleen 
ferritin which had been purified and assessed by 
established methods [5 ] . A horse ferritin cellulose 
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based immuno-adsorbent [6] was originally used to 
purify ferritin antibodies from whole rabbit serum. 
At a later stage rabbit and human ferritin antisera 
were prepared which did not react with the immuno- 
adsorbent. The latter antisera were Rivanol-treated 
before use to remove protein other than y-globulins 
[7]. Ferritin concentrations were determined by an 
immunoradiometric assay [5], Polyacrylamide gel 
electrophoresis was performed on 7% polyacrylamide 
disc gels [8] , Electrophoresis was carried out at room 
temperature with’a constant current density of 5 mA/ 
gel for l-1.5 h. 
2.1. Preparation of affinity matrix 
Sepharose 4B (Pharmacia, Croydon, England) was 
activated with cyanogen bromide as described for 
Ultrogel@ by Doley et al. [9] . A solution of anti- 
ferritin antibody (1 ml) containing 337 lug protein 
was incubated with the cyanogen bromide-activated 
agarose (2 g) at 4°C for 24 h. The antibody matrix 
complex was washed with 0.01 M sodium phosphate 
buffered saline (PBS) pH 7.4 until no protein could 
be detected in the supernatant. The coupling effi- 
ciency was 95%. The antibody-matrix complex was 
then washed with a large volume of 6 M guanidine hydro- 
chloride (pH 3 .l) and subsequently with excess of 
PBS buffer before use. 
2.3. Adsorption and desorp tion 
Serum (1 L), normal or from a patient with 
haemochromatosis undergoing therapeutic venesection 
was incubated with the immunoadsorbent for 2 h at 
4’C with continuous mixing. A solution of human 
spleen ferritin of known concentration was also 
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adsorbed as a control. The charged immunoadsorbent 
was filtered off, packed into a small chromatography 
column (1 X 20 cm) and washed with PBS until the 
optical density was zero. 
2.4.Method A 
Ferritin adsorbed to the affinity matrix was then 
eluted with 6 M guanidine HCl (pH 3 .I). Fractions 
(0.5 ml) containing protein were collected and dialysed 
against 0.1 M sodium acetate at 4°C for 24 h and then 
exhaustively against 0.01 M PBS. The protein contain- 
ing solution was assayed for ferritin content [S] . 
2.5.MethodB 
The charged immunoadsorbent was prepared as 
above and washed with 0.3 M borate buffer,pH 8.6. 
The lower end of the column was closed with a 
dialysis membrane and placed in a buffer reservoir. 
The upper end of the column was fitted with a second 
buffer reservoir. A voltage was then applied to the 
column to maintain a constant current density of 
15 mA using platinum electrodes placed in the buffer 
reservoirs with the anode in the lower chamber. After 
3 h at room temperature ferritin was recovered from 
the chamber (500 ~1) above the dialysis membrane. 
This solution was assayed for ferritin content as above. 
2.6.Method C 
I A glass tube was prepared as for polyacrylamide 
gel electrophoresis. 40% sucrose solution (100 ~1) 
was added, on top of which a polyacrylamide gel 
(5 X 20 mm) was formed. After polymerisation 
the sucrose solution was removed, replaced with 
50 mM Tris-glycine buffer, pH 8.3, and the end 
sealed with a dialysis membrane. The tube &as 
fitted to a polyacrylamide disc-gel electrophoresis 
tank (Shandon) and the buffer reservoir filled with 
the Tris-glycine buffer. The charged matrix was 
pipetted onto the top of the polyacrylamide gel 
and a current density of 5 mA maintained for 1 h. 
The protein containing solution was recovered 
from the chamber above the dialysis membrane 
and analysed by polyacrylamide gel electropho- 
resis for protein and iron. 
II At this point a second adsorption was performed. 
The desorbed protein was readsorbed by recycling 
through a column of the same immunoadsorbent 
(5 X 20 mm) at room temperature for 2 h. The 
recharged immunoadsorbent was then electropho- 
retically desorbed as above (Method C (I)). The 
recovered protein was analysed by polyacrylamide 
gel electrophoresis. 
Table 1 
The recovery of ferritin by different elution procedures 
Pre-adsorption Post-adsorption Eluate % Expected 
Yield 
Guanidine elution (Method A) 
Human Spleen Ferritin 
Norman Human Serum 
Haemochromatotic Serum 
Electrophoretic desorption (Method B) 
1040 787 252.5 100 
43.4 0.5 42.9 99 
820 720 100 40 
Human Spleen Ferritin 1040 792 248 100 
Normal Human Serum 35.6 0.5 34.5 97 
Haemochromatotic Serum 380 145 235 95 
% Expected yield for human spleen ferritin refers to the maximum amount of ferritin adsorbed from excess 
ferritin by the immunoadsorbent (2 g) 
The capacity of the immunoadsorbent, 125 pg ferritin/g immunoadsorbent 
The % expected yield for the serum extracts refers to the total amount of ferritin available or the maximum 
immunoadsorbent capacity if the total ferritin exceeds this 
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3. Results 
3.1. Recovery of fem’tin 
Table 1 shows the ferritin content of samples 
both pre- and post adsorption together with the 
ferritin content of the eluate determined by immuno- 
radiometric assay. Greater than 95% of both 
normal and haemochromatotic serum ferritin was 
adsorbed and successfully eluted by both methods 
(except in the guanidine elution of haemochromatotic 
serum ferritin where the immunosorbent had been 
used in excess of five times and had become less active). 
The ferritin determinations were made soon after 
elution, nevertheless guanidine-eluted protein was 
shown to be unstable and precipitated on standing, 
therefore this method was discontinued. 
3.2. Assessment of purity 
Figure la shows the polyacrylamide gel electro- 
phoretic pattern obtained from the electrophoretically 
desorbed (Method C (I)) human spleen ferritin stained 
for iron with potassium ferocyanide and for protein 
with Coomassie blue. Both the monomeric and dimeric 
forms of ferritin were present and furthermore the 
protein bands stained for iron. 
Figure 1 b shows the gel electrophoretic pattern of 
the normal human serum extract prepared by method C 
(I). This is compared to normal human serum. A 
ferritin protein ratio of about I:40 was found. 
Figure lc shows the gel electrophoretic pattern of 
the serum extract after the second adsorption and sub- 
sequent electrophoretic desorption (Method C (II)). 
A single band of monomeric ferritin was present which 
did not stain for iron. 
4. Discussion 
Previous attempts at the purifications of serum 
ferritin have relied on conventional techniques usually 
employed in the extraction of tissue ferritins where 
the ferritin concentration is high and the losses during 
purification are of little concern [lo] . We have shown 
that immunoadsorption is a rapid and sensitive 
technique capable of extracting small quantities of 
ferritin from solutions of low ferritin concentration 
and high non-ferritin protein content with little or no 
losses and was particularly suitable in the purification 
of serum ferritin. The technique of electrophoretic 
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Fig.lc 
Fig.la. Polyacrylamide gel electrophoresis of purified human 
spleen ferritin following electrophoretic desorption (Method 
C (I)) and stained for iron (Gel i) and protein (Gel ii). 
Fig.lb. Polyacrylamide gel electrophoresis of human serum 
ferritin (purified by Method C (I)), (Gel ii) compared with 
whole serum (Gel i) and stained for protein. 
Fig.lc. Polyacrylamide gel electrophoresis (stained for pro- 
tein) of purified human serum ferritin using Methods C (I) 
and C (II). 
desorption allows the ferritin to be recovered in small 
volumes with no evidence of desorption damage, the 
final extract having a high degree of purity. 
The application of affinity chromatography with 
electrophoretic desorption to the problem of isolating 
tumor specific isoferritins from the serum of patients 
with neoplastic disease needs to be assessed. The iron 
storage protein ferritin is usually present in serum at 
levels which reflect body iron stores [ 1 I] . In malignant 
disease the level is often raised [12-151 and it seems 
likely that at least some of the raised serum ferritin is 
derived from tumour cells [ 161 . Isoelectric focusing 
has demonstr&ted acidic isoferritins which may be 
tumour specific [ 171 and affinity chromatography 
with electrophoretic desorption may prove to be a use- 
ful method of selectively isolating these isoferritins in 
concentration sufficient for further analysis. 
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